Opal Oncology have identified novel assets that have been proven to be potent in killing a range of brain cancer cell lines over current GBM treatments holding out the possibility of increasing life expectancy.
Opal Oncology’s research has been proven to be effective at killing a broader range of common cancer cell lines than current GBM treatments, holding out the possibility of increasing life expectancy over existing treatments.